Urine homogentisic acid and tyrosine: simultaneous analysis by liquid chromatography tandem mass spectrometry

A T Hughes, A M Milan, P Christensen, Gordon Ross, A S Davison, J A Gallagher, J J Dutton, L R Ranganath

Research output: Contribution to journalArticlepeer-review

38 Citations (Scopus)

Abstract

Alkaptonuria (AKU) is a rare debilitating autosomal recessive disorder of tyrosine metabolism. Deficiency of homogentisate 1,2-dioxygenase results in increased homogentisic acid (HGA) which although excreted in gram quantities in the urine, is deposited as an ochronotic pigment in connective tissues, especially cartilage. Ochronosis leads to a severe, early-onset form of osteoarthritis, increased renal and prostatic stone formation and hardening of heart vessels. Treatment with the orphan drug, Nitisinone, an inhibitor of the enzyme 4-hydroxyphenylpyruvate dioxygenase has been shown to reduce urinary excretion of HGA, resulting in accumulation of the upstream pre-cursor, tyrosine. Using reverse phase LC-MS/MS, a method has been developed to simultaneously quantify urinary HGA and tyrosine. Using matrix-matched calibration standards, two product ion transitions were identified for each compound and their appropriate isotopically labelled internal standards. Validation was performed across the AKU and post-treatment concentrations expected. Intrabatch accuracy for acidified urine was 96-109% for tyrosine and 94-107% for HGA; interbatch accuracy (n=20 across ten assays) was 95-110% for tyrosine and 91-109% for HGA. Precision, both intra- and interbatch was
Original languageEnglish
Pages (from-to)106-12
Number of pages7
JournalJournal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences
Volume963
DOIs
Publication statusPublished - 15 Jul 2014

Cite this